Fate Therapeutics joins Cantor Global Healthcare Conference fireside chat on FT819 autoimmune CAR-T program
FATE•Conference fireside chat details
Fate Therapeutics management will join a fireside chat at the on Sept. 9, 2026.
FATE•FATE•FATE•Fate Therapeutics management will join a fireside chat at the on Sept. 9, 2026.
The session is scheduled for 9:45 a.m. EDT in New York.
Discussion will cover FT819 autoimmune data, the start of the Phase 2 RECLAIM-LN lupus nephritis trial, and safety design elements.
